Resistance Trends of Causing Urinary Tract Infections in Chongqing, 2011-2019

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2021 Feb 19

PMID 33603411

Citations 7

Authors

Yanhui Ding

Huijuan Wang

Shuli Pu

Shifeng Huang

Siqiang Niu

Affiliations

Soon will be listed here.

Abstract

Purpose: To analyze the characteristics and trends of drug resistance for (), isolated from urinary tract infections (UTIs), to common antibiotics used in clinics.

Methods: This retrospective study was conducted in a teaching hospital in Chongqing from 2011 to 2019. Laboratory data of isolated bacteria were collected and analyzed.

Results: Among the 17,966 non-repetitive strains isolated from the urine sample, a total of 1543 isolates were identified, with an isolation frequency secondary only to () and there was a peak in the isolates in the year 2013. During the period, the rate of extended-spectrum β-lactamase (ESBL)-producing fell from 48.4% in 2011 to 32.9% in 2019, and a marked jump of resistance was seen in carbapenems from 2.2% to 18.0%. The peak of carbapenem resistance rate (22.6%) to was observed in 2017 along with a low ESBL-producing rate (30.9%). Piperacillin/tazobactam and cefepime resistance levels went up from 4.4% to 25.7% and from 18.2% to 30.5%, respectively. Moreover, the isolates resistance rate to carbapenems and amikacin gradually grew up, showing their peaks in 2017, and then dropped year by year. However, ceftazidime and aztreonam resistance levels were relatively stable, fluctuating between 21.8% and 35.6%, 32.2% and 39.4%, respectively.

Conclusion: There is a significant upward tendency in carbapenem resistance rate and a downward tendency in ESBL-production rate in isolates from UTIs, and continuous surveillance is necessary in the future.

Citing Articles

In the Depths of Wash Water: Isolation of Opportunistic Bacteria from Fresh-Cut Processing Plants.

Kanarek P, Breza-Boruta B, Bogiel T Pathogens. 2024; 13(9).

PMID: 39338959 PMC: 11435197. DOI: 10.3390/pathogens13090768.

Prevalence, regional distribution, and trends of antimicrobial resistance among female outpatients with urine Klebsiella spp. isolates: a multicenter evaluation in the United States between 2011 and 2019.

Kaye K, Gupta V, Mulgirigama A, Joshi A, Ye G, Scangarella-Oman N Antimicrob Resist Infect Control. 2024; 13(1):21.

PMID: 38355621 PMC: 10865585. DOI: 10.1186/s13756-024-01372-x.

Update on Urinary Tract Infection Antibiotic Resistance-A Retrospective Study in Females in Conjunction with Clinical Data.

Mares C, Petca R, Popescu R, Petca A, Multescu R, Bulai C Life (Basel). 2024; 14(1).

PMID: 38255721 PMC: 10820678. DOI: 10.3390/life14010106.

Breaking Antimicrobial Resistance: High-Dose Amoxicillin with Clavulanic Acid for Urinary Tract Infections Due to Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae.

Wilkowski P, Hryniewiecka E, Jasinska K, Paczek L, Ciszek M Ann Transplant. 2023; 28:e939258.

PMID: 37190675 PMC: 10199652. DOI: 10.12659/AOT.939258.

Virulence Genotype and Correlation of Clinical Severeness with Presence of the Type VI Secretion System in Isolates Causing Bloodstream Infections.

Zhang Y, Xu Y, Huang Y Infect Drug Resist. 2022; 15:1487-1497.

PMID: 35411154 PMC: 8994602. DOI: 10.2147/IDR.S353858.

References

Zou C, Wei J, Shan B, Chen X, Wang D, Niu S . In vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam Against Carbapenem-resistant Isolates Collected from Three Secondary Hospitals in Southwest China Between 2018 and 2019. Infect Drug Resist. 2020; 13:3563-3568. PMC: 7567573. DOI: 10.2147/IDR.S273989. View

Pitout J, Nordmann P, Poirel L . Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob Agents Chemother. 2015; 59(10):5873-84. PMC: 4576115. DOI: 10.1128/AAC.01019-15. View

Koeijers J, Verbon A, Kessels A, Bartelds A, Donkers G, Nys S . Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology. 2010; 76(2):336-40. DOI: 10.1016/j.urology.2010.02.052. View

Ulu A, Kurtaran B, Inal A, Komur S, Kibar F, Yapici Cicekdemir H . Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit. 2015; 21:219-24. PMC: 4304439. DOI: 10.12659/MSM.892516. View

Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y . ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2010; 66(2):307-12. DOI: 10.1093/jac/dkq431. View

Arnold R, Thom K, Sharma S, Phillips M, Johnson J, Morgan D . Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J. 2010; 104(1):40-5. PMC: 3075864. DOI: 10.1097/SMJ.0b013e3181fd7d5a. View

Wei J, Zou C, Wang D, Huang A, Niu S . Genetic diversity and in vitro activity of ceftazidime/avibactam and aztreonam/avibactam against imipenem-resistant Enterobacteriaceae isolates in Southwest China: A single-centre study. J Glob Antimicrob Resist. 2020; 22:448-451. DOI: 10.1016/j.jgar.2020.04.023. View

Sokhn E, Salami A, El Roz A, Salloum L, Bahmad H, Ghssein G . Antimicrobial Susceptibilities and Laboratory Profiles of , , and Isolates as Agents of Urinary Tract Infection in Lebanon: Paving the Way for Better Diagnostics. Med Sci (Basel). 2020; 8(3). PMC: 7565412. DOI: 10.3390/medsci8030032. View

Cusack T, Ashley E, Ling C, Roberts T, Turner P, Wangrangsimakul T . Time to switch from CLSI to EUCAST? A Southeast Asian perspective. Clin Microbiol Infect. 2019; 25(7):782-785. PMC: 6587905. DOI: 10.1016/j.cmi.2019.03.016. View

10.

Wang X, Xu X, Li Z, Chen H, Wang Q, Yang P . An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China. Microb Drug Resist. 2013; 20(2):144-9. DOI: 10.1089/mdr.2013.0100. View

11.

van Driel A, Notermans D, Meima A, Mulder M, Donker G, Stobberingh E . Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period. Eur J Clin Microbiol Infect Dis. 2019; 38(11):2151-2158. PMC: 6800841. DOI: 10.1007/s10096-019-03655-3. View

12.

Flores-Mireles A, Walker J, Caparon M, Hultgren S . Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 2015; 13(5):269-84. PMC: 4457377. DOI: 10.1038/nrmicro3432. View

13.

Hu F, Guo Y, Zhu D, Wang F, Jiang X, Xu Y . Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect. 2016; 22 Suppl 1:S9-14. DOI: 10.1016/j.cmi.2016.01.001. View

14.

Jiang Y, Wei Z, Wang Y, Hua X, Feng Y, Yu Y . Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing. Clin Microbiol Infect. 2015; 21(11):1001-7. DOI: 10.1016/j.cmi.2015.07.001. View

15.

Agodi A, Barchitta M, Quattrocchi A, Maugeri A, Aldisio E, Marchese A . Antibiotic trends of Klebsiella pneumoniae and Acinetobacter baumannii resistance indicators in an intensive care unit of Southern Italy, 2008-2013. Antimicrob Resist Infect Control. 2015; 4:43. PMC: 4632366. DOI: 10.1186/s13756-015-0087-y. View

16.

DeLeo F, Chen L, Porcella S, Martens C, Kobayashi S, Porter A . Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A. 2014; 111(13):4988-93. PMC: 3977278. DOI: 10.1073/pnas.1321364111. View

17.

Federico M, Furtado G . Immediate and later impacts of antimicrobial consumption on carbapenem-resistant Acinetobacter spp., Pseudomonas aeruginosa, and Klebsiella spp. in a teaching hospital in Brazil: a 10-year trend study. Eur J Clin Microbiol Infect Dis. 2018; 37(11):2153-2158. DOI: 10.1007/s10096-018-3352-1. View

18.

Guh A, Limbago B, Kallen A . Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States. Expert Rev Anti Infect Ther. 2014; 12(5):565-80. PMC: 6494086. DOI: 10.1586/14787210.2014.902306. View

19.

Xiao Y, Zhang J, Zheng B, Zhao L, Li S, Li L . Changes in Chinese policies to promote the rational use of antibiotics. PLoS Med. 2013; 10(11):e1001556. PMC: 3833832. DOI: 10.1371/journal.pmed.1001556. View

20.

Sun J, Huang S, Yang S, Pu S, Zhang C, Zhang L . Impact of carbapenem heteroresistance among clinical isolates of invasive Escherichia coli in Chongqing, southwestern China. Clin Microbiol Infect. 2015; 21(5):469.e1-10. DOI: 10.1016/j.cmi.2014.12.013. View